openPR Logo
Press release

Sustainable Pharmaceutical Packaging Market Industry Outlook, Future Trends, Insights, Quality Analysis, and Sustainable Growth Strategies for the Period of 2023-2029 | Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical

08-02-2023 10:11 AM CET | IT, New Media & Software

Press release from: ReportsnReports

Sustainable Pharmaceutical Packaging Market Industry

๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐’๐ฎ๐ฌ๐ญ๐š๐ข๐ง๐š๐›๐ฅ๐ž ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ฉ๐š๐œ๐ค๐š๐ ๐ข๐ง๐  ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐Ÿ๐ซ๐จ๐ฆ ๐”๐’๐ƒ๐Ÿ•๐Ÿ.๐Ÿ” ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ๐Ÿ’๐Ÿ”.๐Ÿ‘ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•, ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ“.๐Ÿ’% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•.

๐Ÿ”ฅ ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐๐ƒ๐… ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ + ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐“๐Ž๐‚ โžก๏ธ https://www.reportsnreports.com/contacts/requestsample.aspx?name=6800743

The key players in the sustainable pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US).. The study includes an in-depth competitive analysis of these key players in the sustainable pharmaceutical packaging market, with their company profiles, and key market strategies.

Sustainable pharmaceutical packaging is an important aspect of the healthcare industry, as it protects the integrity of the medication and aims to reduce the environmental impact of packaging materials. With an increasing focus on reducing waste and preserving natural resources, pharmaceutical companies are exploring new and innovative ways to create functional and eco-friendly packaging. This includes using recyclable materials, designing for easy recycling, and implementing packaging reduction strategies

"Glass accounted for the third largest share amongst other raw material in the pharmaceutical packaging market."

Glass is an amorphous and crystalline material with excellent transparency and chemical inertness. It is mainly used in the primary packaging of pharmaceutical drugs. Various types of primary packaging, such as vials, ampoules, bottles, containers, and syringes, are made from glass. Glass is a permanent material that is infinitely recyclable and reusable, reducing waste and saving natural resources. This means that glass has the potential to be recycled over and over again without any loss of its intrinsic properties. Permanent materials are perfect for maintaining a truly circular material loop. Due to the strength of their chemical bonds, permanent materials are not damaged by the recycling process and can stay in the recycling loop as long as they are properly collected, treated, and re-melted.

"Secondary packaging to be the second largest packaging type in molded fiber pulp packaging during the forecast period."

Secondary packaging in sustainable pharmaceutical packaging refers to the outer packaging that encloses the primary packaging, which contains the actual medication. It protects the primary packaging and provides information about the product, such as the dosage, expiration date, and manufacturer. Secondary packaging is also known as retail-ready packaging (RRP), shelf-ready packaging (SRP), or counter-top display units (CDUs). The packaging makes it easier for retailers to display and handle products. Using sustainable materials in secondary packaging is becoming increasingly important in the pharmaceutical industry as companies aim to reduce their environmental impact.

"Recyclable process accounted for the largest share of sustainable pharmaceutical packaging during the forecast period."

The use of recyclable plastics in the sustainable pharmaceutical packaging industry is becoming increasingly important as companies and consumers become more aware of the impact of packaging materials. Recyclable plastics, such as PET and HDPE, can be used to create packaging that is not only environmentally friendly but also cost-effective and safe for the storage and transportation of pharmaceutical products. One of the main benefits of using recyclable plastics in pharmaceutical packaging is that it reduces the amount of waste that ends up in landfills. These materials can be easily collected, sorted, and recycled, which helps conserve natural resources and reduce the industry's carbon footprint. Additionally, recyclable plastics are often lightweight, making them more cost-effective to transport and store. They also have good barrier properties that protect products from moisture, light, and other environmental factors

"Europe is to be the second largest market for sustainable pharmaceutical packaging"

The high demand for pharmaceutical packaging in the region can be attributed to the increasing research, production, and distribution of pharmaceuticals. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. At present, consumers, manufacturers, retailers, advocacy groups, and governments across the region are encouraging environmentally friendly packaging thus contributing to the consistent growth of the sustainable pharmaceutical packaging industry in countries such as Germany, France, and the UK, owing to their environmentally-conscious consumers. All these factors are expected to fuel the demand for sustainable pharmaceutical packaging in the Europe region.

This study has been validated through primaries conducted with various industry experts worldwide. These primary sources have been divided into 3 categories, namely by company, by designation, and by region.

By Department- Sales/Export/Marketing - 53.5%, Production- 23.3%, CXOs - 23.3%
By Designation- Managers- 60.5%, CXOs- 23.3%, Executives- 16.3%
By Region- North America- 33%, Europe- 27%, Asia Pacific- 25%, South America - 5%, and Middle East & Africa - 10%

โžก๏ธ ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐…๐จ๐ซ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=6800743

Reasons to Buy the Report

From an insight perspective, this research report focuses on various levels of analyses - industry analysis (industry trends), market ranking of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the sustainable pharmaceutical packaging market; high growth regions; and market drivers, restraints, opportunities, and challenges

Research Coverage

This report provides detailed segmentation of the sustainable pharmaceutical packaging market and forecasts its market size until 2027. The market has been segmented based on raw material, product type, packaging type, process and region. The report also provides detailed information on company profiles and competitive strategies adopted by the key players to strengthen their positions in the market. The report also provides insights into the driving and restraining factors in the sustainable pharmaceutical packaging market, along with opportunities and challenges across these industries. It also includes profiles for top manufacturers in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sustainable Pharmaceutical Packaging Market Industry Outlook, Future Trends, Insights, Quality Analysis, and Sustainable Growth Strategies for the Period of 2023-2029 | Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical here

News-ID: 3152415 • Views: โ€ฆ

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presentsโ€ฆ
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer โ€ฆ
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing theโ€ฆ
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March โ€ฆ
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achievingโ€ฆ
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S โ€ฆ
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buyingโ€ฆ

All 5 Releases


More Releases for Pharmaceutical

Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P โ€ฆ
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans. Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.โ€ฆ
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran โ€ฆ
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with developmentโ€ฆ
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong โ€ฆ
Global Mevastatin Market Sizeย research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value forโ€ฆ
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma โ€ฆ
Global Specialty Pharmaceutical Industry Synopsis: The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers. The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%โ€ฆ
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles โ€“ Hongyua โ€ฆ
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially inโ€ฆ
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti โ€ฆ
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in Northโ€ฆ